ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 162 filers reported holding ANTARES PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $226,000 | +11.9% | 55,235 | -2.3% | 0.10% | +8.2% |
| Q4 2021 | $202,000 | +9.2% | 56,535 | +10.8% | 0.10% | +1.0% |
| Q3 2021 | $185,000 | -16.7% | 51,045 | 0.0% | 0.10% | -20.7% |
| Q2 2021 | $222,000 | +5.7% | 51,045 | -0.3% | 0.12% | -3.2% |
| Q1 2021 | $210,000 | +0.5% | 51,195 | -2.5% | 0.12% | -10.1% |
| Q4 2020 | $209,000 | +60.8% | 52,495 | +9.1% | 0.14% | +36.3% |
| Q3 2020 | $130,000 | – | 48,095 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |